Resveratrol and desferoxamine protect human OxLDL-treated granulosa cell subtypes from degeneration. | J Clin Endocrinol Metab;99(1): 229-39, 2014 Jan. | MEDLINE

Main content 1 Search 2 Footer 3

+A A -A High contrast

VHL Regional Portal

Information and Knowledge for Health

Advanced Search EVID@Easy

Resveratrol and desferoxamine protect human OxLDL-treated granulosa cell subtypes from degeneration.

Schube, U; Nowicki, M; Jogschies, P; Blumenauer, V; Bechmann, I; Serke, H.

Affiliation

Schube U; Institute of Anatomy (U.S., M.N., I.B., H.S.), University of Leipzig, D-04103 Leipzig, Germany; and Clinic for Reproductive Medicine and Gynecological Endocrinology (P.J., V.B.), D-04103 Leipzig, Germany.

J Clin Endocrinol Metab ; 99(1): 229-39, 2014 Jan.

Article in En | MEDLINE | ID: mdl-24170104

Subject(s)

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Stilbenes / Cytoprotection / Deferoxamine / Granulosa Cells / Lipoproteins, LDL / Antioxidants Limits: Female / Humans Language: En Journal: J Clin Endocrinol Metab Year: 2014 Document type: Article Affiliation country: Country of publication:

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Stilbenes / Cytoprotection / Deferoxamine / Granulosa Cells / Lipoproteins, LDL / Antioxidants Limits: Female / Humans Language: En Journal: J Clin Endocrinol Metab Year: 2014 Document type: Article Affiliation country: Country of publication: